NCT07532863

A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants

A Retrospective Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus Participants in Southeast Asia

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 400 (estimated)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: 40 Years – 70 Years
• Healthy volunteers: —

Summary

The purpose of the study is to investigate the cardiovascular disease (CVD) risk profile among participants newly diagnosed with type 2 diabetes mellitus (T2DM) in Southeast Asia (CRISTAL SEA). It's a retrospective chart-review across five Southeast Asian countries to characterize newly diagnosed T2DM participants and how their CVD risk is distributed, using data from the year before diagnosis and roughly the first year after diagnosis.

Conditions

• Diabetes Mellitus, Type 2

Interventions

Type	Name	Description
OTHER	No treatment given	No treatment given

Timeline

• Start date: 2026-03-13
• Primary completion: 2026-07-01
• Completion: 2026-07-01
• First posted: 2026-04-16
• Last updated: 2026-04-16

Locations

1 site across 1 country: Singapore